Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
Dover
G J
GJ
Charache
S
S
Nora
R
R
Boyer
S H
SH
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D001374:Azacitidine / Q000627:therapeutic use* / Q000633:toxicity; D001853:Bone Marrow / Q000187:drug effects; D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D004920:Erythropoiesis; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use* / Q000633:toxicity; D012156:Reticulocytes / Q000378:metabolism; D013789:Thalassemia / Q000188:drug therapy* / Q000378:metabolism
D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea